Luke Halpern

Misinformation, limited understanding of biosimilars, and inconsistent insurance policies only add to the confusion.

As hospitals and health systems aim to improve outcomes, pharmacists have a large role in managing these conditions with pregnancy-specific therapies.

Inviting members of Congress into the pharmacy helps legislators experience first hand the value that pharmacists bring to their communities.

Bipartisan support—in a polarized Congress—underscores the importance of pharmacy benefit manager reform.

Perhaps unsurprisingly, GLP-1 therapies are expected to continue making headlines within the industry.

Pharmacists need support—through partnerships and reimbursement—to provide more diverse services to patients.

Sustainable health care models require buy-in from multiple stakeholders, including pharmacists, payers, and patients.

Study results indicate that using salt substitutes can be a viable population-wide strategy in preventing cardiovascular disease and controlling hypertension.